Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Israel

European Research Council grant · Running

InterictalSleepDetct Non-invasive detection of interictal epileptiform discharges (IEDs) in the mesial temporal lobe (MTL) during sleep

Coordinator
Tel Aviv University, Israel
Runs
1 April 2024 to 30 September 2025
Status
Running
EU funding
€150k
Total cost
—
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101158226

What the project is doing

In the project's own words, from its summary on CORDIS.

Interictal epileptic discharges (IEDs) are pathological brain activities involving sharp spikes in electrical field potentials that occur preferentially during sleep. In epilepsy, IEDs occur between seizures, and often in deep brain regions such as the medial temporal lobe (MTL). IEDs during sleep disrupt memory and are associated with cognitive impairments. Importantly, MTL IEDs occur not only in epilepsy but also in multiple neuropsychiatric conditions including Alzheimers Disease (AD), Autism, ADHD, and following traumatic brain injury (TBI).

A major unmet need is to automatically detect sleep IEDs non-invasively when they occur in deep regions such as the MTL, a task that was believed to be nearly impossible until now. We recently developed a novel machine learning-based tool to reliably detect a subset of MTL IEDs non-invasively with high precision. For the first time, IEDs originating in the MTL can be detected even when gold-standard visual inspection by clinical neurologists is impossible.

We will first conduct research to optimize and validate IED detection in epilepsy patients, and in mild cognitive impairment (MCI) and AD patients. We will then work to commercialize the tool so that it can be widely used to improve diagnosis, prognosis, drug titration, and risk-stratification not only in epilepsy and dementia, but in diverse neurological conditions including TBI, ADHD, Autism, and psychiatric disorders.

Together with the technology transfer office of TAU and with business partners already on board we will work to consolidate and extend the systems patent family and bring our detection tool to the market.

Topics

Who is involved

OrganisationCityCountryRole
Tel Aviv UniversityTel AvivIsraelCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI